Evidence map›Paper›PMID 41495719›Full record

ArticleBMC public health2026

The impact of national context on COVID-19 vaccine hesitancy across Europe.

Michael Bergmann, Arne Bethmann, Tessa-Virginia Hannemann, Alexander Tobias Schumacher, Nikolaos Theodoropoulos

Abstract read
In one paragraph

Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Michael BergmannSHARE BERLIN Institute (SBI), Chausseestr. 111, 10115, Berlin, Germany. mbergmann@share-berlin.eu.
Arne BethmannSHARE BERLIN Institute (SBI), Chausseestr. 111, 10115, Berlin, Germany.
Tessa-Virginia HannemannSHARE BERLIN Institute (SBI), Chausseestr. 111, 10115, Berlin, Germany.
Alexander Tobias SchumacherSHARE BERLIN Institute (SBI), Chausseestr. 111, 10115, Berlin, Germany.
Nikolaos TheodoropoulosDepartment of Economics, University of Cyprus, 1 Panepistimiou Avenue, Aglantzia, Nicosia, 2109, Cyprus.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study investigates vaccine hesitancy among the 50 + population in Europe during the COVID-19 pandemic, focusing on the role of national contexts alongside individual determinants. The framework is guided by the WHO’s Complacency, Convenience, and Confidence (3Cs) model to explore factors influencing vaccination intent.

methodsData from over 45,000 SHARE Corona Survey respondents aged 50 + from 26 European countries were analysed regarding their intent to receive the COVID-19 vaccine. Multilevel logistic regression models assessed associations with individual factors (socio-demographics, health, and economic conditions) and country-level indicators of complacency (mortality, containment policies), convenience (human development, health expenditure), and confidence (perceived vaccine safety and effectiveness, trust in authorities).

resultsKey findings suggest that higher COVID-19 mortality rates and stricter containment measures were tied to an increase in vaccine uptake by 2.8% points. Furthermore, trust in the vaccine itself, rather than in health authorities and governments, was associated with an increase in vaccination intent by 2.1% points.

conclusionsOur study reveals significant national disparities in vaccination attitudes and behaviours, linked to socio-economic factors and healthcare quality. The research highlights the interplay between individual and national factors, suggesting that successful vaccination campaigns require a holistic approach addressing both personal hesitations and systemic barriers. This research hence underscores the importance of public trust, robust healthcare systems, and targeted communication strategies to mitigate vaccine hesitancy and improve pandemic response outcomes.

Indexed as

COVID-19COVID-19 VaccinesVaccination HesitancyAgedEuropeFemaleHumansMaleMiddle AgedPandemicsSocioeconomic FactorsSurveys and QuestionnairesTrustCOVID-19 Vaccines3C modelContext effectsCountry-level weightsCross-country comparisonMultilevel modelSHAREVaccine hesitancyWHO

Identifiers

PMID41495719
PMCPMC12922216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.